The simultaneous analysis of tumor and germline samples allowed the identification of somatic variants present in low frequency (<10%), and the detection of LOH in tumors from six patients with germline pathogenic/likely pathogenic variants in BRCA1 or BRCA2. Here, BRCA2 is linked to neoplasm.